OUT PATIENT TREATMENT: COMMUNITY AND PRIVATE PRACTICE SUPPORT SYSTEMSGALLANT DM.1983; JOURNAL OF CLINICAL PSYCHIATRY; ISSN 0160-6689; USA; DA. 1983; VOL. 44; NO 6; SECT. 2; PP. 15-22; BIBL. 35 REF.Article

INTRAMUSCULAR LOXAPINE (LOXITANE): RAPID TRANQUILLIZATION OF ACUTELY DISTURBED SCHIZOPHRENIC PATIENTSDEAN GA; GALLANT DM.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 25; NO 6; PP. 721-725; BIBL. 2 REF.Article

TACITIN: A PRELIMINARY EVALUATION IN CHRONIC ALCOHOLIC PATIENTS PRESENTING THE TARGET SYMPTOMATOLOGY OF ANXIETY = LA TACITINE: EVALUATION PRELIMINAIRE CHEZ DES PATIENTS ALCOOLIQUES CHRONIQUES PRESENTANT LA SYMPTOMATOLOGIE CIBLE DE L'ANXIETEGALLANT DM; SWANSON WC.1973; CURR. THERAPEUT. RES.; U.S.A.; DA. 1973; VOL. 15; NO 3; PP. 113-115; BIBL. 3 REF.Serial Issue

MOLINDONE: A CONTROLLED EVALUATION OF THE INTRAMUSCULAR ANTIPSYCHOTIC PREPARATION.MIELKE DH; GALLANT DM.1977; CURR. THERAPEUT. RES.; U.S.A.; DA. 1977; VOL. 22; NO 3; PP. 356-360; BIBL. 2 REF.Article

U-28, 774 (KETOZOLAM): AN EARLY EVALUATION OF A NEW ANTIANXIETY AGENTGALLANT DM; GUERRERO FIGUEROA R; SWANSON WC et al.1973; CURR. THERAPEUT. RES.; U.S.A.; DA. 1973; VOL. 15; NO 3; PP. 123-126; BIBL. 5 REF.Serial Issue

2-DIMETHYLAMINOETHANOL (DEANOL) IN CHRONIC SCHIZOPHRENIA.PAUL SM; GALLANT DM; MIELKE DH et al.1976; RES. COMMUNIC. PSYCHOL. PSYCHIATRY BEHAV.; U.S.A.; DA. 1976; VOL. 1; NO 1; PP. 183-186; BIBL. 14 REF.Article

CLORAZEPATE DIPOTASSIUM (TRANXENE): A CONTROLLED EVALUATION IN ALCOHOLIC PATIENTS AFTER WITHDRAWALMIELKE DH; GALLANT DM; MCFARLAIN RA et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 19; NO 5; PP. 506-511; BIBL. 3 REF.Article

COMPARISON OF MUSCLE RELAXATION WITH PLACEBO MEDICATION FOR ANXIETY REDUCTION IN ALCOHOLIC INPATIENTS.MCFARLAIN RA; MIELKE DH; GALLANT DM et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 2; PP. 173-176; BIBL. 7 REF.Article

A CONTROLLED EVALUATION OF PROPRANOLOL IN CHRONIC ALCOHOLIC PATIENTS PRESENTING THE SYMPTOMATOLOGY OF ANXIETY AND TENSIONGALLANT DM; SWANSON WC; GUERRERO FIGUEROA R et al.1973; J. CLIN. PHARMACOL.; U.S.A.; DA. 1973; VOL. 13; NO 1; PP. 41-43; BIBL. 3REF.Serial Issue

AN EVALUATION OF A UNIQUE NEW ANTIPSYCHOTIC AGENT, SULPIRIDE: EFFECTS ON SERUM PROLACTIN AND GROWTH HORMONE LEVELS.MIELKE DH; GALLANT DM; KESSLER C et al.1977; AMER. J. PSYCHIATRY; U.S.A.; DA. 1977; VOL. 134; NO 12; PP. 1371-1375; BIBL. 26 REF.Article

HALOPERIDOL: A PRELIMINARY EVALUATION OF A NEW LONG-ACTING AQUEOUS SUSPENSION FOR INTRAMUSCULAR INJECTIONMIELKE DH; GALLANT DM; KESSLER C et al.1978; CURR. THERAPEUT. RES.; USA; DA. 1978; VOL. 24; NO 5; PP. 551-558; BIBL. 4 REF.Article

LENPERONE: A CONTROLLED EVALUATION IN CHRONIC SCHIZOPHRENIC PATIENTS.MIELKE DH; GALLANT DM; KESSLER C et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 636-640; BIBL. 5 REF.Article

ORF-8063: AN EARLY EVALUATION OF A NEW ANTIANXIETY AGENTGALLANT DM; SWANSON WC; MIELKE DH et al.1972; CURR. THERAPEUT. RES.; U.S.A.; DA. 1972; VOL. 14; NO 10; PP. 664-666; BIBL. 4REF.Serial Issue